Regular monitoring by a healthcare provider is necessary to adjust the dose appropriately for optimal glycemic control
When you eat, semaglutide stimulates insulin production, which may cause low blood sugar (glucose) levels, especially in people with diabetes
*Because semaglutide is used in patients already at higher risk of vascular and ocular complications (diabetes, obesity, hypertension), teasing out the independent effect is difficult
As glucose-lowering agents, GLP-1 RAs stimulate insulin secretion in a glucose-dependent manner, theoretically minimizing the risk of hypoglycemia
Interestingly, our natural levels of GHK-Cu decline significantly with age, which parallels the loss of skin firmness, slower healing, and thinning hair that so many people notice over time